Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Location
6030 S. Rice Ave., Suite C, Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 210 % +36.7%
Quick Ratio 1.56 % -64.7%
Debt-to-equity 233 % -57.1%
Return On Equity 39.6 %
Return On Assets 15 %
Operating Margin 36.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.07M shares +30.1%
Common Stock, Shares, Outstanding 6.91M shares +32.4%
Entity Public Float 18.2M USD -87.5%
Common Stock, Value, Issued 7K USD +34.2%
Weighted Average Number of Shares Outstanding, Basic 6.7M shares +31.4%
Weighted Average Number of Shares Outstanding, Diluted 7.18M shares +40.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 981M USD +236%
General and Administrative Expense 46.6M USD +23.6%
Costs and Expenses 441M USD +96.9%
Operating Income (Loss) 359M USD +1249%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 327M USD
Income Tax Expense (Benefit) 63.7M USD +2121%
Net Income (Loss) Attributable to Parent 121M USD
Earnings Per Share, Basic 20 USD/shares
Earnings Per Share, Diluted 19 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 166K USD -99.6%
Accounts Receivable, after Allowance for Credit Loss, Current 62.7M USD +17.9%
Inventory, Net 3.16M USD +39.8%
Other Assets, Current 314M USD
Assets, Current 473M USD +315%
Deferred Income Tax Assets, Net 0 USD
Operating Lease, Right-of-Use Asset 27.4M USD +139%
Intangible Assets, Net (Excluding Goodwill) 21.6M USD +35.9%
Goodwill 13.9M USD +0%
Other Assets, Noncurrent 499K USD
Assets 965M USD +120%
Accounts Payable, Current 19.8M USD +15.2%
Liabilities, Current 185M USD +175%
Deferred Income Tax Liabilities, Net 15M USD +339%
Operating Lease, Liability, Noncurrent 30.4M USD +113%
Other Liabilities, Noncurrent 310M USD
Liabilities 526M USD +46.8%
Retained Earnings (Accumulated Deficit) -298M USD +28.8%
Stockholders' Equity Attributable to Parent 317M USD +425%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 438M USD +449%
Liabilities and Equity 965M USD +120%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 51M USD +1570%
Net Cash Provided by (Used in) Financing Activities -6.81M USD -220%
Net Cash Provided by (Used in) Investing Activities -64K USD +91.3%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 6.91M shares +32.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.7M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 608K USD +10.9%
Deferred Tax Assets, Valuation Allowance 944K USD -87.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure +49.3%
Deferred Tax Assets, Gross 74.5M USD +13.9%
Payments to Acquire Property, Plant, and Equipment 64K USD -91.3%
Property, Plant and Equipment, Gross 113M USD +10.8%
Operating Lease, Liability, Current 2.11M USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +100%
Deferred Income Tax Expense (Benefit) -2.5M USD -2532%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD -100%
Additional Paid in Capital 615M USD +28.4%
Amortization of Intangible Assets 1.4M USD -6.67%
Depreciation, Depletion and Amortization 20.6M USD +0.62%
Share-based Payment Arrangement, Expense 15.9M USD
Interest Expense 17.6M USD +27.9%